Bruker Corporation (BRKR) Stock Analysis
Bruker Corporation (BRKR) is a publicly traded company in the HEALTHCARE sector. It trades at $57.31, carries a market capitalization of $8.90B. This page summarizes the public market data, fundamentals, and frequently asked questions for BRKR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.
Sector: HEALTHCARE - MEDICAL DEVICES
Exchange: NASDAQ
Key Metrics
- Price: $57.31
- Market Cap: $8.90B
- EPS: $-0.24
- 52-Week High: $58.98
- 52-Week Low: $28.41
Market Sentiment
Bruker Corporation currently has a Bullish sentiment score of 0.36.
About Bruker Corporation
Bruker Corporation is a premier global provider of scientific instruments and analytical solutions, catering to a wide array of industries such as life sciences, materials research, and diagnostics. With its headquarters in Billerica, Massachusetts, the company boasts a robust international presence, operating in North America, Europe, and Asia Pacific. Bruker is well-regarded for its innovative product offerings, fostering advancements in scientific discovery and healthcare by delivering pre...
GNG Research Analysis
GNG Research scores Bruker Corporation (BRKR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for BRKR.
Frequently Asked Questions
Does BRKR pay dividends?
Bruker Corporation (BRKR) does not currently pay a regular dividend.
What is BRKR's market cap?
Bruker Corporation (BRKR) has a market capitalization of $8.90B with a current stock price of $57.31.